The androgen receptor (AR) regulates prostate cell growth in man, and prostate cancer is the
commonest cancer in men in the UK. We present a comprehensive analysis of AR binding …

Defining the transition from benign to malignant tissue is fundamental to improving early
diagnosis of cancer 1 . Here we use a systematic approach to study spatial genome integrity in …

Background Clinical prognostic groupings for localised prostate cancers are imprecise, with
30–50% of patients recurring after image-guided radiotherapy or radical prostatectomy. We …

Context : Prebiopsy multiparametric magnetic resonance imaging (mpMRI) is increasingly
used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI is …

This review found that alpha-adrenoceptor antagonists reduced stent-related pain and storage
symptoms after placement of a ureteral stent. These initial results are likely to be reliable, …

Background Hypoxia is associated with a poor prognosis in prostate cancer. This work aimed
to derive and validate a hypoxia-related mRNA signature for localized prostate cancer. …

Molecular characterization of genome-wide association study (GWAS) loci can uncover key
genes and biological mechanisms underpinning complex traits and diseases. Here we …

Prostate-specific membrane antigen (PSMA) is overexpressed in most prostate adenocarcinoma
(AdPC) cells and acts as a target for molecular imaging. However, some case reports …

Prostate cancer is heterogeneous and patients would benefit from methods that stratify
those who are likely to respond to systemic therapy. Here, we employ single-cell assays for …

Background Radiotherapy enhances innate and adaptive anti-tumour immunity. It is unclear
whether this effect may be harnessed by combining immunotherapy with radiotherapy …